These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35414206)

  • 21. A Strong Synergy Between the Thiopeptide Bacteriocin Micrococcin P1 and Rifampicin Against MRSA in a Murine Skin Infection Model.
    Ovchinnikov KV; Kranjec C; Telke A; Kjos M; Thorstensen T; Scherer S; Carlsen H; Diep DB
    Front Immunol; 2021; 12():676534. PubMed ID: 34276663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human skin microbiota is a rich source of bacteriocin-producing staphylococci that kill human pathogens.
    O'Sullivan JN; Rea MC; O'Connor PM; Hill C; Ross RP
    FEMS Microbiol Ecol; 2019 Feb; 95(2):. PubMed ID: 30590567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful Development of Bacteriocins into Therapeutic Formulation for Treatment of MRSA Skin Infection in a Murine Model.
    Ovchinnikov KV; Kranjec C; Thorstensen T; Carlsen H; Diep DB
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32958719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
    Akram FE; El-Tayeb T; Abou-Aisha K; El-Azizi M
    Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):48. PubMed ID: 27530257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Phage- and Bacteriocin-Based Therapies in Combatting Nosocomial MRSA Infections.
    Walsh L; Johnson CN; Hill C; Ross RP
    Front Mol Biosci; 2021; 8():654038. PubMed ID: 33996906
    [No Abstract]   [Full Text] [Related]  

  • 26. Combating biofilms of foodborne pathogens with bacteriocins by lactic acid bacteria in the food industry.
    Pang X; Song X; Chen M; Tian S; Lu Z; Sun J; Li X; Lu Y; Yuk HG
    Compr Rev Food Sci Food Saf; 2022 Mar; 21(2):1657-1676. PubMed ID: 35181977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-adhesion and Anti-inflammatory Potential of the Leaderless Class IIb Bacteriocin Enterocin DD14.
    Teiar R; Pérez-Ramos A; Zgheib H; Cudennec B; Belguesmia Y; Drider D
    Probiotics Antimicrob Proteins; 2022 Aug; 14(4):613-619. PubMed ID: 35604525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteriocins as alternative agents for control of multiresistant staphylococcal strains.
    Nascimento JS; Ceotto H; Nascimento SB; Giambiagi-Demarval M; Santos KR; Bastos MC
    Lett Appl Microbiol; 2006 Mar; 42(3):215-21. PubMed ID: 16478507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300.
    Thomsen TT; Mojsoska B; Cruz JC; Donadio S; Jenssen H; Løbner-Olesen A; Rewitz K
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5427-36. PubMed ID: 27381394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lantibiotic gallidermin acts bactericidal against Staphylococcus epidermidis and Staphylococcus aureus and antagonizes the bacteria-induced proinflammatory responses in dermal fibroblasts.
    Bengtsson T; Lönn J; Khalaf H; Palm E
    Microbiologyopen; 2018 Dec; 7(6):e00606. PubMed ID: 29536668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci.
    Sandiford S; Upton M
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1539-47. PubMed ID: 22155816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (II).
    Cheng C; Liu Y; Song H; Pan L; Li J; Qin Y; Li R
    Mar Drugs; 2013 Aug; 11(8):2927-48. PubMed ID: 23955285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class I and Class II Lanthipeptides Produced by Bacillus spp.
    Barbosa J; Caetano T; Mendo S
    J Nat Prod; 2015 Nov; 78(11):2850-66. PubMed ID: 26448102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diversity of the bacteriocins, their classification and potential applications in combat of antibiotic resistant and clinically relevant pathogens.
    Choi GH; Holzapfel WH; Todorov SD
    Crit Rev Microbiol; 2023 Sep; 49(5):578-597. PubMed ID: 35731254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriocin-Based Synergetic Consortia: a Promising Strategy to Enhance Antimicrobial Activity and Broaden the Spectrum of Inhibition.
    Soltani S; Biron E; Ben Said L; Subirade M; Fliss I
    Microbiol Spectr; 2022 Feb; 10(1):e0040621. PubMed ID: 35170996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-microbial Peptides against Methicillin-resistant
    Sinoliya P; Solanki PS; Piplani S; Kumar Niraj RR; Sharma V
    Curr Protein Pept Sci; 2023; 24(2):156-177. PubMed ID: 36529917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Development of Thiazole-Containing Compounds as Potential Antibacterials against Methicillin-Resistant
    Liu H; Xu T; Xue Z; Huang M; Wang T; Zhang M; Yang R; Guo Y
    ACS Infect Dis; 2024 Feb; 10(2):350-370. PubMed ID: 38232301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteriocins from lactic acid bacteria as an alternative to antibiotics.
    Ołdak A; Zielińska D
    Postepy Hig Med Dosw (Online); 2017 May; 71(0):328-338. PubMed ID: 28513457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined analysis of transcriptomics and metabolomics provide insights into the antibacterial mechanism of bacteriocin XJS01 against multidrug-resistant Staphylococcus aureus.
    Ying JP; Fu CM; Wu YC; Chen YM; Liu XY; Zhang QL; Liu H; Liang MZ
    Sci Total Environ; 2024 Mar; 917():170412. PubMed ID: 38281634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-Activity Relationships of the Bacteriocin Bactofencin A and Its Interaction with the Bacterial Membrane.
    Bédard F; Fliss I; Biron E
    ACS Infect Dis; 2019 Feb; 5(2):199-207. PubMed ID: 30540905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.